Patients who are involved in a clinical protocol driven 12 week medical weight loss intervention will be randomized to receive either a placebo or 600 mg of an ashwagandha root extract. The study endpoints are primarily the patients self-reported perception of life stress and sleep quality. The working hypothesis of this study is that the addition of aschwagandha to .the medical weight loss program will improve the self-reported perception of life stress and sleep quality
During this 12-week medical weight loss program, the randomized patients will also have a baseline measurements and final measurements of blood for selected adipokines , cytokines, and telomerase measurements
| Condition | Stress Fracture, dyssomnia, adiposity, Obesity, Obesity, Sleep Disorders, Sleep Disorders, Sleep Disorders (Pediatric), Sleep Disorders (Pediatric), Stress Reaction, Craving, sleep disorder, sleep disturbances, sleep problem, sleep disturbance, trouble sleeping, sleep dysfunction, difficulty sleeping, problems with sleeping, disturbed sleep |
|---|---|
| Treatment | Placebo Capsule, Ashwagandha Root Extract Capsule |
| Clinical Study Identifier | NCT03112824 |
| Sponsor | Loma Linda University |
| Last Modified on | 3 July 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.